Ip Group Regulatory News (IPO)

IP Group plc - Investor presentation on Life Sciences

IP Group plc (LSE: IPO) ("IP Group" or "the Company"), which develops world-changing science and technology businesses across life sciences, technology and cleantech, is pleased to announce that it will host an investor presentation titled 'Life Sciences: Changing Medicine'on Wednesday 30 November 2022.

The event, which will be led by Dr Sam Williams, Managing Partner of Life Sciences, will be hybrid (both in person and virtual) and take place from 9am - 11am. For further information and to register to attend, please visit the events section of our website: https://www.ipgroupplc.com/events.

The online update will be hosted through the Investor Meet Company platform. Questions can be submitted in advance of the event via the Investor Meet Company Platform up to 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free via: https://www.investormeetcompany.com/ip-group-plc/register-investor. Investors who already follow IP Group plc on the Investor Meet Company platform will automatically be invited.

No material new information will be released by the Company during the presentation.

For more information, please contact:

Notes for editors

About IP Group

IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech. The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

For more information, please visit our website at www.ipgroupplc.com.

ENDS